Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 10/20 | 0.66 |
| ▸ | PI4K2B | Q8TCG2 | 10/20 | 0.66 |
| ▸ | PI4K2A | Q9BTU6 | 10/20 | 0.66 |
| ▸ | PI4KB | Q9UBF8 | 10/20 | 0.66 |
| ▸ | ADORA2A | P29274 | 12/20 | 0.51 |
| ▸ | ADORA1 | P30542 | 8/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.45 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.45 |
| ▸ | GMPS | P49915 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9397052 | 0.83 | PI4K2A (0.59) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL27438888 | 0.78 | PI4KA (0.67) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL10650083 | 0.72 | PI4KA (0.59) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL23969763 | 0.69 | PI4K2A (0.56) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL10649999 | 0.69 | PI4K2A (0.51) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL26972743 | 0.69 | TAS1R3 (0.71) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL29588968 | 0.69 | RET (0.48) | PI4KAPI4K2BPI4K2API4KB | |
| SCHEMBL9687602 | 0.69 | PI4KA (0.54) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL9687595 | 0.69 | PI4KA (0.54) | PI4KAPI4K2BPI4K2API4KBADORA2A | |
| SCHEMBL1924594 | 0.68 | ADORA2A (1.00) | PI4KAPI4K2BPI4K2API4KBADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113544122-A | Cyclopentyl nucleoside analogs as antiviral agents | 詹森生物制药有限公司 | 2021-10-22 | — | — | CN | disclosed |
| EP-0708781-B1 | A 3 ADENOSINE RECEPTOR AGONISTS | USA (US) | 2001-10-04 | — | — | EP | disclosed |
| US-5773423-A | XANTHINE RIBOSIDES | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-06-30 | — | — | US | disclosed |
| EP-0708781-A1 | A 3 ADENOSINE RECEPTOR AGONISTS | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1996-05-01 | — | — | EP | disclosed |
| WO-1995002604-A1 | A3 ADENOSINE RECEPTOR AGONISTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-01-26 | — | — | WO | disclosed |